Wellness, Intervention Strategies and HIV Care

a study on HIV/AIDS Substance Abuse

Summary

Eligibility
for females ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
study ends around
Principal Investigator
by Jennifer P Jain, PhD

Description

Summary

This is a pilot trial designed to assess the feasibility and acceptability of an intervention aimed at improving adherence to antiretroviral therapy (ART), viral suppression, and engagement in HIV care. The intervention will address behavioral coping strategies, HIV care engagement behaviors, and substance use management.

Keywords

HIV, Substance Use Disorder (SUD), Substance Use, Risk Reduction, Behavioral Intervention, Public Health, Intervention Program, Substance-Related Disorders, Wellness, Intervention Strategies and HIV Care (WISH)

Eligibility

You can join if…

Open to females ages 18 years and up

• Participants must:

  • Be at least 18 years of age
  • Self-report biological characteristics consistent with the population under study
  • Be HIV-positive
  • Report use of at least one of the following substances in the last 90 days:
    • Cannabis
    • Methamphetamine
    • Cocaine/crack
    • Cocaine
    • Heroin
    • Non-prescribed opioids (e.g., fentanyl, morphine)
    • Ecstasy
    • Phencyclidine (PCP)
    • Psychedelics (e.g., Lysergic acid diethylamide, mescaline, ketamine)
    • Poppers (alkyl nitrites)
    • Non-prescribed benzodiazepines (e.g., Valium, Xanax, Klonopin, Librium)
    • Barbiturates
  • Be English-speaking
  • Be able and willing to provide informed consent

You CAN'T join if...

  • Evidence of severe cognitive impairment or active psychosis that may impede ability to provide fully informed consent, determined by the research assistants and clinical supervisor(s)
  • The research staff are trained on guidelines for identifying participants who exhibit signs of inability to meaningfully participate or provide consent due to mental illness or impairment

Locations

  • SF MWCCS Site Office accepting new patients
    San Francisco California 94115 United States
  • Oakland MWCCS Site Office accepting new patients
    Oakland California 94612 United States

Lead Scientist at UCSF

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT07069374
Study Type
Interventional
Participants
Expecting 50 study participants
Last Updated
Contact us about this trial